|
1) Rennard S, Decramer M, Calverley PMA, et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of confronting COPD international survey. Eur Respir J. 2002; 20: 799-805
|
|
|
|
2) Smith CA, Harrison DL. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet. 1997; 350: 630-3
|
|
|
|
|
|
3) Smolonska J, Wijmenga C, Postma DS, et al. Meta-analyses on suspected chronic obstructive pulmonary disease genes. Am J Respir Crit Care Med. 2009; 180: 618-31
|
|
|
|
|
|
4) 山口佳寿博. 慢性閉塞性肺疾患(COPD)と喫煙感受性規定遺伝子. 慶應医学. 2004; 81: 23-30
|
|
|
|
|
5) Hunninghake GM, Cho MH, Tesfaigzi Y, et al. MMP12, lung function, and COPD in high-risk populations. N Engl J Med. 2009; 361: 2599-608
|
|
|
|
|
|
6) Givelber RJ, Courpmitree NN, Gottlieb DJ, et al. Segregation analysis of pulmonary function among families in the Framingham study. Am J Respir Crit Care Med. 1998; 157: 1445-51
|
|
|
|
|
|
7) Silverman EK, Chapman HA, Drazen JM, et al. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998; 157: 1770-8
|
|
|
|
|
|
8) Redline S, Tishler PV, Rosner B, et al. Genotypic and phenotypic similarities in pulmonary function among family members of adult monozygotic and dizygotic twins. Am J Epidemiol. 1989; 129: 827-36
|
|
|
|
|
|
9) Centers for Disease Control and Prevention. Current estimates from the National Health Interview Survey, 1995. In: Vital and Health Statistics. Washington DC: Government Printing Office, DHHS publication no. 96-1527
|
|
|
|
|
|
10) Silverman EK, Weiss ST, Drazen JM, et al. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000; 162: 2152-8
|
|
|
|
|
|
11) Patel BD, Coxson HO, Pillai SG, et al. Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008; 178: 500-5
|
|
|
|
|
|
12) Wilk JB, Chen T, Gottlieb DJ, et al. A genome-wide association study of pulmonary function measures in the Framingham heart study. PLoS Genet. 2009; 5: e1000429
|
|
|
|
|
|
13) Repapi E, Sayers I, Wain LV, et al. Genome-wide association study identifies five loci associated with lung function. Nat Genet. 2010; 42: 36-44
|
|
|
|
|
|
14) Hancock DB, Eijgelsheim M, Wilk JB, et al. Meta-analyses of genome-wide association studies identify multiple novel loci associated with pulmonary function. Nat Genet. 2010; 42: 45-52
|
|
|
|
|
|
15) Pillai SG, Ge D, Zhu G, et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Gent. 2009; 5: e1000421
|
|
|
|
|
|
16) DeMeo DL, Mariani T, Bhattacharya S, et al. Integration of genomic and genetic approaches implicates IREB2 as a COPD susceptibility gene. Am J Hum Genet. 2009; 85: 493-502
|
|
|
|
|
|
17) Cho MH, Boutaoui N, Klanderman BJ, et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet. 2010; 42: 200. doi: 10. 1038/ng. 535
|
|
|
|
|
|
18) Kong X, Cho MH, Anderson W, et al. Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema. Am J Respir Crit Care Med. 2011; 183: 43-9
|
|
|
|
|
|
19) Savale L, Chaouat A, Bastuji-Carin S, et al. Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009; 179: 566-71
|
|
|
|
|
|
20) Fraying TM, Timpson NJ, Weedon MN, et al. A common variant in the fto gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007; 316: 889-94
|
|
|
|
|
|
21) Wan ES, Cho MH, Boutaoui N, et al. Genome-wide association analysis of body mass in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2011 ;45:304-10. 2010; doi: 10. 111165/rcmb. 2010-0294oc
|
|
|
|
|
|
22) Pillai SG, Kong X, Edwards LD, et al. Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010; 182: 1498-505
|
|
|
|
|
|
23) GOLD Executive Committee. Global Strategy for the Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2010. Updated 2010. The US National Heart, Lung, and Blood Institute and the World Health Organization. http/www.gold.copd.org/
|
|
|
|
|
|
24) 日本呼吸器学会COPDガイドライン第3版作成委員会. COPD(慢性閉塞性肺疾患)診断と治療のためのガイドライン 第3版. 東京: メディカルレビュ-社; 2009
|
|
|
|
|
|
25) Yamaguchi K, Onizawa S, Tsuji T, et al. How to evaluate “spirometric" lung age - what method is approvable？ Respir Physiol Neurobiol. 2011; 178: 349-51. doi: 10. 1016/j. resp. 2011. 06. 012
|
|
|
|
|
|
26) Maneckjee R, Minna JD. Opioids induce while nicotine suppresses apoptosis in human lung cancer cells. Cell Growth Differentiation. 1994; 5: 1033-40
|
|
|
|
|
|
27) West KA, Brognard J, Clark AS, et al. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest. 2003; 111: 81-90
|
|
|
|
|
|
28) Dasgupta P, Chellappan S. Nicotine-mediated cell proliferation and angiogenesis. Cell Cycle. 2006; 5: 2324-8
|
|
|
|
|
|
29) Caporaso N, Gu F, Chatterjee N, et al. Genome-wide and candidate gene association study of cigarette smoking behavior. PLoS Genet. 2009; 4: e4653
|
|
|
|
|
|
30) Thorgeiresson T, Gudbjartsson DF, Surakka I, et al. Sequence variations at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet. 2010; 42: 448-53
|
|
|
|
|
|
31) Amos CI, Wu X, Broderick P, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25. 1. Nat Genet. 2008; 40: 616-22
|
|
|
|
|
|
32) Young RP, Hopkins RJ, Whittington CF, et al. Individual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after sub-phenotyping for COPD. PLoS ONE. 2011; 6: e16476
|
|
|
|
|